DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Garcia G, Magnan A, Chiron R. et al.
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.
Chest 2013;
144: 411-419
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.